The following is a summary of “Comparative analysis of the safety and feasibility of laparoscopic and open approaches for right anterior sectionectomy,” published in the December 2024 issue of Oncology by Li et al.
Laparoscopic hepatectomy offers minimally invasive advantages, but data on laparoscopic right anterior sectionectomy (LRAS) are limited.
Researchers conducted a retrospective study comparing LRAS and open right anterior sectionectomy (ORAS) in people with liver lesions.
They enrolled 39 people who underwent LRAS (n=18) or ORAS (n=21) between January 2015 and September 2023. The preoperative data, intraoperative details, and postoperative outcomes were also compared.
The results showed that people undergoing LRAS experienced significantly less blood loss (P=0.019), had a shorter hospital stay (P=0.045), and had a higher rate of bile leak (P=0.039) compared to those undergoing ORAS. There were no significant differences in operative time (P=0.156), transfusion rate (P=0.385), hospital expenses (P=0.511), or complications, including postoperative white blood cell count, alanine aminotransferase (ALT), and aspartate aminotransferase (AST) levels (P>0.05). Disease-free survival (P=0.351) and OS (P=0.613) were similar between the 2 groups in people with hepatocellular carcinoma.
They concluded that LRAS was a safe and feasible procedure, offering advantages over open surgery for lesions in the right anterior lobe of the liver.
Source: nature.com/articles/s41598-024-80148-0
The post Surgical Outcomes of LRAS vs ORAS in Hepatocellular Carcinoma first appeared on Physician's Weekly.